Alvimopan, a peripherally acting muopioid receptor pamor antagonist for the treatment of opioidinduced bowel dysfunction. Entereg fda prescribing information, side effects and uses. Nationally, the prescription of opioids for acute and chronic pain is increasing. Alvimopan and enhanced recovery pathways in colorectal. Farydak panobinostat capsules, a histone deacetylase inhibitor, in combination with bortezomib and dexamethasone, is indicated for the treatment of patients with multiple myeloma who have received at least 2 prior regimens, including bortezomib and an immunomodulatory agent. Entereg alvimopan dosing, indications, interactions. Delaney cp, fazio vw, senagore aj, robinson b, halverson al, remzi fh 2001 fast track postoperative management protocol for patients with high comorbidity undergoing complex abdominal and pelvic colorectal surgery. It binds muopioid receptors in the gut, thereby selectively inhibiting the negative opioid effects on gi. See full prescribing information for complete boxed warning. Sep 01, 2014 the product labeling approved in october 20 for the expanded use of alvimopan broadened the previous verbiage from use following partial large or small bowel resection to use following surgeries that include partial bowel resection emphasis added.
Table 1 presents treatmentemergent adverse reactions reported in. Which medications in the drug class peripherallyacting mu. Dsuvia sufentanil sublingual tablet, 30 mcg hcp home. Alvimopan entereg for the management of postoperative ileus in. Alvimopan entereg american academy of family physicians.
Entereg was administered 30 minutes to 5 hours before the scheduled start of surgery and then twice daily until hospital discharge or for a maximum of 7 days of postoperative treatment. Alvimopan is contraindicated for use in patients who have taken therapeutic doses of opioids for more than 7 consecutive days immediately before starting alvimopan. The searchable database may not contain all of the available information on a particular topic. The approved dosing regimen includes an initial do. In 2008, alvimopan entereg was approved by the food and drug. Pharmacist information sheet important dispensing information for every patient, dispense temodar in a separate vial or in its original package, making sure each container lists the strength per capsule and that patients take the appropriate number of capsules from each package or vial. Entereg is not recommended for use in patients with severe hepatic impairment childpugh class c see use in specific populations and clinical pharmacology package insert. Apr 15, 2011 alvimopan entereg is an oral, peripherallyacting muopioid receptor antagonist used to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel. As opioid use continues to expand and become of increased concern for healthcare practitioners, so do the adverse. Alvimopan entereg also has limited ability to cross the bloodbrain barrier and. Highlights of prescr ibing information these highlights do not include all the information needed to use symproic safely and effectively. Opioid receptors mediate opioid analgesia in the central nervous system cns and gastrointestinalrelated effects in the periphery. Apr 21, 2018 entereg is not recommended for use in patients with severe hepatic impairment childpugh class c see use in specific populations and clinical pharmacology package insert. Gastrointestinal adverse reactions in opioid tolerant patients.
A randomized, placebocontrolled phase 3 trial study sb767905. Alvimopan entereg capsules prescribing information. Alvimopan entereg pre oppostop 30 40020 general alvimopan entereg orders patient criteria for alvimopan entereg use. Entereg rems program is to mitigate the potential risk of myocardial infarction by. Alvimopan in the setting of colorectal resection with an. A higher number of myocardial infarctions was reported in patients treated with entereg 0. Entereg rems program kit has been received by the hospital and education on.
Food and drug administration fda approved alvimopan entereg, adolorglaxosmithkline, a selective, quaternary, peripherally acting muopioid receptor pamor antagonist, for accelerating upper and lower gi tract recovery after partial largebowel or smallbowel resection with primary anastomosis. Consequences of postoperative ileus include increased patient discomfort, delayed time to adequate nutrition, prolonged length of stay, and increased cost to the patient and healthcare system. Entereg alvimopan dose, indications, adverse effects. Alvimopan entereg for the treatment of postoperative ileus. Entereg alvimopan capsules, prescribing information exton, pa.
Alvimopan is a drug approved by the food and drug administration fda and is used to help. Licensing, codevelopment and marketing agreement for. Alvimopan entereg, a peripherally acting muopioid receptor. This indication is approved under accelerated approval based on progressionfree survival. Entereg capsules, 12 mg, are blue, hardgelatin capsules printed with adl2698 on both the body and the cap of the capsule.
Relistor methylnaltrexone bromide tablet relistor methylnaltrexone bromide injection, solution salix pharmaceuticals, inc. If you cannot find the information you need by searching the online database, please submit a medical question or call the merck national service center by phone at 18006726372 for immediate assistance. Alvimopan trade name entereg is a drug which behaves as a peripherally acting. The evolving role of longterm pharmacotherapy for opioid. Two trials have been published to evaluate alvimopans efficacy for the treatment of oic, and the available data for alvimopan use for oic. The entereg full prescribing information has a boxed warning that states entereg is available only for shortterm 15 doses use in hospitalized. Entereg can be taken with or without food see clinical pharmacology 12. Alvimopan entereg alvimopan is a peripherally acting muopioid receptor antagonist. Entereg accelerated the time to recovery of gi function and reduced the time to hospital discharge order written as compared to placebo.
Entereg capsules are available in unitdose packs of 30 capsules 30 doses ndc 6791902010 for hospital use only. Sufentanil sublingual tablet 30 mcg for the management of pain following abdominal surgery. However the logistics involved in procuring, storing and dispensing the drug and the. Results from a randomized, doubleblind, placebocontrolled, dosefinding study in subjects taking opioids for. Highlights of prescr ibing information gastrointestinal. Ensuring that entereg alvimopan is used only for shortterm use no more than 15 doses in a hospital inpatient setting. Each health care professional who uses this service retains sole responsibility for decisions regarding patient care. Targeted treatment options for opioid induced constipation. Entereg is an opioid antagonist indicated to accelerate the time to upper and lower gastrointestinal recovery following surgeries that. Study protocol and statistical analysis plan pdf may 9, 2018.
Dec 02, 2020 entereg capsules, 12 mg, are blue, hardgelatin capsules printed with adl2698 on both the body and the cap of the capsule. Poi is multifactorial, contributing factors include the release of inflammatory mediators and endogenous opioids after surgery\. Impact of alvimopan entereg on hospital costs after. The endpoint of these studies was time to achieve recovery of both upper and lower gi function, reported as gi2 data in the package insert, representing resolution of poi. Alvimopan entereg for the treatment of postoperative. Professional information requests for merck products. Alvimopan entereg alvimopan is another pamora that is indicated for the prevention and treatment of postoperative ileus following bowel surgery. Before prescribing entereg, please read the accompanying prescribing information, including the boxed warning about potential risk of myocardial infarction. Planned surgery is for partial large or small bowel resection with primary anastomosis.
Patient has not taken therapeutic doses of opioids for more than seven 7 consecutive days immediately prior to. Alvimopan and enhanced recovery pathways in colorectal surgery. Minkowitz hs, leiman d, melson t, singla n, didonato kp, palmer pp. Entereg alvimopan capsules prescribing information. Development of peripheral opioid antagonists mayo clinic. Pamoras peripherally acting mu opioid receptor antagonists. Consequences of postoperative ileus include increased patient discomfort. Trial of alvimopan in major spine surgery full text view. Entereg is available only to hospitals that perform bowel resections and are enrolled in the e. Alvimopan entereg is an oral, peripherallyacting muopioid receptor antagonist used to accelerate the time to upper and lower gastrointestinal recovery following partial large or small bowel. Uc san diego pharmacoeconomic forum skaggs school of.
Aug 10, 2020 postoperative ileus poi and constipation are common secondary effects of opioids and carry significant clinical and economic impacts. In one longterm 12month clinical study of alvimopan in patients treated with. Postoperative ileus, a temporary cessation in bowel motility, is a common and significant complication of major surgery. Entereg is available only through a restricted program for shortterm use 15 doses called the entereg access support and education e.
Pdf alvimopan entereg for the management of postoperative. No dosage adjustment is necessary in patients with mildtosevere renal impairment, but they should be monitored for adverse effects. Alvimopan entereg, approved by the fda to accelerate upper and lower gastrointestinal gi recovery following partial largebowel or small bowel resection with primary anastomosis, represents a. Movantik is a prescription medicine used to treat constipation that is caused by prescription pain medicines called opioids, in adults with longlasting chronic pain that is not caused by active cancer. Licensing, codevelopment and marketing agreement for entereg. Patients recently exposed to opioids are expected to. Alvimopan entereg alvimopan entereg indication partial bowel resection surgery to accelerate the time to upper and lower gi recovery not for opioid induced constipation mechanism of action selective antagonist of muopioid receptor peripherally alvimopan package insert. Alvimopan is indicated to accelerate the time to gastrointestinal recovery following partial bowel resection with primary anastomosis. Goal of the entereg alvimopan capsules rems program. New drugs of 2008 for pharmacy technicians disclosures. Poi is multifactorial, contributing factors include the release of inflammatory mediators and endogenous.
536 616 642 1409 953 132 1647 1144 1002 315 537 1018 958 1417 721 182 1257 25 1303 1279 1620 1221 1533 1652 1282 1590 1369 1588 1614 572